Zenlabs Ethica Standalone December 2018 Net Sales at Rs 17.01 crore, down 7.98% Y-o-Y
February 05, 2019 / 05:39 PM IST
Reported Standalone quarterly numbers for Zenlabs Ethica are:Net Sales at Rs 17.01 crore in December 2018 down 7.98% from Rs. 18.49 crore in December 2017.
Quarterly Net Profit at Rs. 0.24 crore in December 2018 down 45.8% from Rs. 0.44 crore in December 2017.
EBITDA stands at Rs. 0.43 crore in December 2018 down 34.85% from Rs. 0.66 crore in December 2017.
Zenlabs Ethica EPS has decreased to Rs. 0.36 in December 2018 from Rs. 0.71 in December 2017.
Zenlabs Ethica shares closed at 59.20 on February 04, 2019 (BSE) and has given 203.59% returns over the last 6 months and 294.67% over the last 12 months.
| Zenlabs Ethica | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'18 | Sep'18 | Dec'17 | | Net Sales/Income from operations | 17.01 | 14.50 | 18.49 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 17.01 | 14.50 | 18.49 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 15.53 | 10.45 | 14.87 | | Increase/Decrease in Stocks | -2.40 | 0.34 | 0.06 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.79 | 0.83 | 0.72 | | Depreciation | 0.05 | 0.05 | 0.05 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 2.74 | 2.19 | 2.19 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.31 | 0.65 | 0.60 | | Other Income | 0.07 | -- | 0.00 | | P/L Before Int., Excpt. Items & Tax | 0.38 | 0.65 | 0.61 | | Interest | 0.02 | 0.02 | 0.02 | | P/L Before Exceptional Items & Tax | 0.36 | 0.63 | 0.59 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.36 | 0.63 | 0.59 | | Tax | 0.12 | 0.18 | 0.15 | | P/L After Tax from Ordinary Activities | 0.24 | 0.45 | 0.44 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 0.24 | 0.45 | 0.44 | | Equity Share Capital | 6.51 | 6.20 | 6.20 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.36 | 0.73 | 0.71 | | Diluted EPS | 0.36 | 0.73 | 0.71 | | EPS After Extra Ordinary | | Basic EPS | 0.36 | 0.73 | 0.71 | | Diluted EPS | 0.36 | 0.73 | 0.71 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
_2020091018165303jzv.jpg "Decoding The World Of ETF")
CBI books UK-based Cambridge Analytica for 'illegally harvesting data' of Facebook users in India Watch more 
Ideas For Profit | Hamara Bajaj: Strong export demand of two-wheelers, long-term positive outlook Watch more 
Bharat Biotech's Covaxin found to be safe, induced immune response in Phase-1 Watch more 
5 die in Serum Institute of India fire in Pune; no impact on Covishield Watch more 
